EXPERIMENTAL BIOLOGY AND MEDICINE

Scope & Guideline

Empowering researchers with open access to vital discoveries.

Introduction

Explore the comprehensive scope of EXPERIMENTAL BIOLOGY AND MEDICINE through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore EXPERIMENTAL BIOLOGY AND MEDICINE in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1535-3702
PublisherFRONTIERS MEDIA SA
Support Open AccessYes
CountryUnited States
TypeJournal
Convergefrom 1996 to 2024
AbbreviationEXP BIOL MED / Exp. Biol. Med.
Frequency18 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressAVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE CH-1015, SWITZERLAND

Aims and Scopes

The journal 'Experimental Biology and Medicine' aims to publish high-quality research that advances the understanding of biological processes and their applications in medicine. It covers a broad range of topics, with a focus on experimental studies that bridge the gap between basic science and clinical practice.
  1. Translational Research:
    The journal emphasizes translational research that translates basic scientific discoveries into clinical applications, addressing health challenges and improving patient outcomes.
  2. Innovative Therapeutic Approaches:
    Research on novel therapeutic strategies, including drug development, gene therapy, and regenerative medicine, is a core focus, highlighting innovative methods to treat various diseases.
  3. Mechanistic Studies:
    Studies elucidating the underlying biological mechanisms of diseases, particularly at the molecular and cellular levels, are prominently featured to enhance understanding of pathophysiology.
  4. Systems Biology and Bioinformatics:
    The integration of systems biology and bioinformatics approaches is encouraged to analyze complex biological data, identify biomarkers, and predict therapeutic responses.
  5. Interdisciplinary Approaches:
    The journal promotes interdisciplinary research that combines insights from biology, medicine, engineering, and computational sciences to tackle complex health issues.
  6. Clinical and Experimental Studies:
    A balance of clinical and experimental studies is maintained, with a focus on the application of experimental findings to clinical settings.
Recent publications in 'Experimental Biology and Medicine' reveal several emerging trends and themes that reflect the evolving landscape of biomedical research. These trends indicate a shift towards more complex, integrative approaches to understanding health and disease.
  1. Precision Medicine:
    There is a significant increase in research focused on precision medicine, which tailors treatment strategies based on individual genetic, environmental, and lifestyle factors, enhancing therapeutic efficacy.
  2. Neuroinflammation and Neurological Disorders:
    Recent studies increasingly address the role of neuroinflammation in various neurological disorders, highlighting the importance of understanding immune responses in the central nervous system.
  3. Microbiome Research:
    Research exploring the role of the microbiome in health and disease is gaining traction, with studies investigating how gut flora influences metabolic processes, immune function, and disease susceptibility.
  4. Regenerative Medicine and Stem Cell Therapy:
    There is a rising interest in regenerative medicine, particularly the application of stem cell therapies for tissue repair and the treatment of degenerative diseases.
  5. Artificial Intelligence in Healthcare:
    The integration of artificial intelligence and machine learning techniques in biomedical research is emerging as a critical area, with applications ranging from drug discovery to personalized treatment plans.
  6. Immunotherapy and Cancer Research:
    Immunotherapy continues to be a major focus, with increasing research into novel immune-based therapies for cancer treatment and the mechanisms underlying immune evasion by tumors.

Declining or Waning

In recent years, several research themes appear to have lost prominence in 'Experimental Biology and Medicine'. This decline may reflect shifts in scientific priorities or advancements in other areas that overshadow previous interests.
  1. Traditional Pharmacology:
    Research focused solely on traditional pharmacological approaches is less popular, as the field increasingly shifts towards personalized medicine and targeted therapies.
  2. Basic Animal Models:
    While animal studies remain important, there is a noticeable decline in publications using basic animal models without translational relevance, as researchers seek more sophisticated models that better mimic human diseases.
  3. Single-Factor Studies:
    The trend towards studies examining single factors or variables in isolation is waning, with a growing preference for multi-factorial studies that consider complex interactions.
  4. In vitro Studies without Clinical Relevance:
    In vitro studies that do not connect to clinical implications or therapeutic applications are being published less frequently, as the journal emphasizes studies with direct relevance to human health.
  5. Epidemiological Studies without Molecular Insights:
    Epidemiological studies that lack molecular or mechanistic insights into the diseases studied are becoming less prominent, reflecting a preference for research that integrates population data with biological understanding.

Similar Journals

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Pioneering Discoveries in Molecular Disease Research
Publisher: ELSEVIERISSN: 0925-4439Frequency: 12 issues/year

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, published by Elsevier, is a pivotal journal in the fields of Molecular Biology and Molecular Medicine, recognized for its high impact factor and robust ranking within Scopus categories, holding prestigious quartiles in Q1 for both disciplines as of 2023. With ISSN 0925-4439 and E-ISSN 1879-260X, this journal fosters cutting-edge research from 1990 to 2025, addressing the critical molecular mechanisms underlying human diseases. Its wide-ranging scope includes original research articles, reviews, and advanced theoretical insights, serving as an essential resource for researchers, clinicians, and students alike. The journal is based in the Netherlands, at RADARWEG 29, 1043 NX AMSTERDAM, and while it does not currently offer an open-access option, it continues to maintain a strong presence in the scientific community, enhancing our understanding of molecular processes in health and disease.

CURRENT MOLECULAR MEDICINE

Empowering Research for Tomorrow’s Medical Breakthroughs
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1566-5240Frequency: 10 issues/year

CURRENT MOLECULAR MEDICINE is a pivotal journal fostering advancements in the interdisciplinary fields of molecular medicine, biochemistry, and genetics. Published by Bentham Science Publishers, this esteemed journal has been disseminating vital research findings since its inception in 2001 and is continuously dedicated to exploring the molecular basis of health and disease. With a focus on translational research, CURRENT MOLECULAR MEDICINE provides an invaluable platform for researchers, healthcare professionals, and students, making significant contributions to the understanding of molecular mechanisms and therapeutic strategies. With an ISSN of 1566-5240 and an E-ISSN of 1875-5666, the journal holds a commendable position within the scientific community, being ranked Q3 in Biochemistry and Molecular Biology and Q2 in Medicine (miscellaneous) as of 2023. This journal does not currently operate on an open access model but remains accessible through various institutional subscriptions. The multidisciplinary scope covering molecular biology to medicinal applications positions CURRENT MOLECULAR MEDICINE as an essential resource for those striving to meet the challenges of modern healthcare and biomedical research.

Biomedical Research and Therapy

Pioneering discoveries that shape the future of health.
Publisher: BIOMEDPRESSISSN: 2198-4093Frequency: 12 issues/year

Biomedical Research and Therapy is a pioneering journal published by BIOMEDPRESS, dedicated to the field of biomedical sciences. With its ISSN 2198-4093, this journal aims to disseminate high-quality research and innovative therapies that advance knowledge in biomedical research. Although it operates on a non-open access model, it provides crucial insights into various topics such as drug discovery, disease mechanisms, regenerative medicine, and clinical applications. The journal's rigorous peer-review process ensures the publication of critical findings and methodologies, making it a vital resource for researchers, practitioners, and students interested in the constantly evolving landscape of biomedical research. With converged years from 2020 to 2024 and an emerging reputation in its field, Biomedical Research and Therapy is positioned to contribute significantly to the global scientific community, enriching the discourse around therapeutic advancements and biomedical innovations.

Molecular Biomedicine

Unraveling Biochemical Mysteries for Better Health
Publisher: SPRINGERNATUREISSN: Frequency: 1 issue/year

Molecular Biomedicine is a prestigious peer-reviewed journal published by SpringerNature, dedicated to advancing the fields of molecular biology and molecular medicine. With a commendable Q1 ranking in both categories for 2023, this journal stands out for its rigorous exploration of the biochemical processes underlying health and disease. Operating out of Germany, Molecular Biomedicine aims to provide comprehensive insights into cutting-edge research, facilitating interdisciplinary collaboration among researchers, healthcare professionals, and students alike. The journal's impact is reflected in its Scopus rankings, placing it in the upper echelons of the fields of biochemistry, genetics, and molecular biology. As an open access platform, it commits to disseminating knowledge widely, ensuring that pivotal discoveries are accessible to all. Researchers looking to publish in a dynamic environment that prioritizes innovation and application in the biomedical sciences will find Molecular Biomedicine an ideal outlet for their work.

Journal of Extracellular Vesicles

Innovating Insights: Pioneering Research on Extracellular Vesicles
Publisher: WILEYISSN: Frequency: 12 issues/year

Journal of Extracellular Vesicles, published by WILEY, stands at the forefront of research in the evolving fields of Cell Biology and Histology as a prestigious open-access journal that has been disseminating groundbreaking findings since 2012. With a commendable impact exemplified by its Q1 ranking in both categories for 2023, this journal offers an invaluable platform for researchers, professionals, and students to explore the critical roles of extracellular vesicles in cellular communication, disease pathology, and therapeutics. The journal is indexed in leading databases, ensuring wide visibility and accessibility of its content, which supports the collaborative spirit of scientific discovery. Featuring innovative research and comprehensive reviews, the Journal of Extracellular Vesicles not only maintains a high standard of scholarship but also fosters a community dedicated to advancing our understanding of these small yet significant cellular components.

FASEB BioAdvances

Pioneering Discoveries in Physiology and Genetics
Publisher: WILEYISSN: Frequency: 12 issues/year

FASEB BioAdvances, published by WILEY, is an esteemed open-access journal dedicated to advancing the fields of biochemistry, molecular biology, and physiology. Since its inception in 2019, the journal has rapidly established a significant presence within the academic community, boasting an impressive impact factor reflective of its Q2 and Q3 standings across various categories, including Biochemistry, Genetics and Molecular Biology, Cancer Research, Molecular Medicine, and Physiology. The journal aims to disseminate high-quality research and innovative findings to enhance the understanding of biological processes, making it a vital resource for researchers, professionals, and students alike. With its commitment to open access, FASEB BioAdvances ensures that groundbreaking research is available to a global audience, facilitating collaboration and exploration in these rapidly evolving scientific domains.

BioScience Trends

Exploring the Intersection of Science and Health
Publisher: IRCA-BSSAISSN: 1881-7815Frequency: 6 issues/year

BioScience Trends, published by IRCA-BSSA, is a leading academic journal based in Japan that significantly contributes to the fields of biochemistry, genetics, molecular biology, and social health sciences. With an impactful Scopus ranking that places it in the 97th percentile for health social sciences and the 89th percentile for general biochemistry, this journal is an essential resource for researchers and professionals alike. Since its inception in 2007, BioScience Trends has fostered high-quality research dissemination and collaboration, offering a platform for innovative studies and insights that are vital for advancing knowledge in life sciences. Despite being a non-open access publication, it maintains rigorous standards and a reputable presence in the academic community, with an impressive categorization into Q1 and Q2 quartiles as of 2023. Researchers, students, and professionals seeking to stay at the forefront of scientific exploration and health advancements will find BioScience Trends to be an invaluable source for scholarly articles and emerging trends in their respective fields.

Current Medical Science

Unveiling the Latest Trends in Medical Science
Publisher: SPRINGERISSN: 2096-5230Frequency: 6 issues/year

Current Medical Science is a prominent academic journal dedicated to advancing knowledge in the fields of Medicine, Biochemistry, and Genetics. Published by SPRINGER with an ISSN of 2096-5230 and E-ISSN 2523-899X, this journal is based in China and serves as a vital resource for researchers, professionals, and students alike. With a focus on innovative research and emerging trends, Current Medical Science has established itself with an impactful presence, operating under Open Access guidelines to ensure wide dissemination of scientific findings. The journal's recognition is underscored by its impressive Scopus rankings, including a Q3 quartile placement in Biochemistry and Genetics as of 2023. It is noteworthy that the journal spans converged years from 2018 to 2024, providing a comprehensive platform for scholarly discussions and developments that drive the evolution of medical science. As it continues to publish influential research, Current Medical Science plays an essential role in bridging the gap between laboratory science and clinical application.

Biology Direct

Elevating your understanding of biology.
Publisher: BMCISSN: Frequency: 1 issue/year

Biology Direct is a leading open-access journal published by BMC, dedicated to disseminating groundbreaking research in the fields of biological sciences. Since its inception in 2006, the journal has emerged as a pivotal platform for scholars, researchers, and practitioners, providing unrestricted access to high-quality, peer-reviewed articles that cover a wide spectrum of topics, including biochemistry, ecology, and applied mathematics. With an impressive ranking in the first quartile across multiple scientific categories, including Agricultural and Biological Sciences and Biochemistry, Genetics, and Molecular Biology, Biology Direct is recognized for its rigorous standards and impactful contributions within the academic community. The journal's open-access model ensures that research findings reach a global audience, fostering collaboration and innovation. Researchers and students looking to stay ahead in the rapidly evolving biological sciences will find Biology Direct an invaluable resource for knowledge and insight.

BMB Reports

Unlocking Knowledge for a Healthier Tomorrow
Publisher: KOREAN SOCIETY BIOCHEMISTRY & MOLECULAR BIOLOGYISSN: 1976-6696Frequency: 12 issues/year

BMB Reports is a distinguished open-access journal published by the Korean Society of Biochemistry & Molecular Biology since 2008, making significant contributions to the fields of biochemistry, molecular biology, and medicine. With a current impact factor that positions it in the Q2 category for Biochemistry and Q1 for Miscellaneous Medicine, this journal supports a wide dissemination of high-quality research findings, fostering robust dialogue among researchers, professionals, and students alike. Based in Seoul, South Korea, BMB Reports aims to publish innovative studies that advance our understanding of biochemical and molecular processes, thus shaping the future of health and medicine. The journal's commitment to open access enhances the visibility of its articles, allowing for greater accessibility and engagement in the scientific community. With notable rankings in both the Biochemistry and Molecular Biology categories, BMB Reports stands as a vital resource for those seeking to stay at the forefront of research in these rapidly evolving disciplines.